Therapeutics development in SMA

Spinal Muscular Atrophy Microchapters
Home
Patient Info
Overview
Epidemiology and Demographics
Risk Factors
Screening
Other forms
Molecular Biology
Genetics
Types
Diagnosis
Diagnosis
Full Differential Diagnosis
Symptom
Physical Examination
Electrolyte & Biomarker Studies
Electrocardiogram
Chest X Ray
MRI and CT
Echocardiography or Ultrasound
Other Imaging Findings
Pathology
Other Diagnostic Studies
Treatment
Outcome measures
Therapeutics development
Indications For Surgery
Research
Pre-Operative Assessment
Post-Operative Assessment
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Therapeutics development in SMA Resources
Most recent articles on Therapeutics development in SMA
Most cited articles on Therapeutics development in SMA
Review articles on Therapeutics development in SMA
Review articles on Therapeutics development in SMA
CME Programs on Therapeutics development in SMA
Powerpoint slides on Therapeutics development in SMA
Images of Therapeutics development in SMA
Ongoing Trials on Therapeutics development in SMA at Clinical Trials.gov
US National Guidelines Clearinghouse on Therapeutics development in SMA
NICE Guidance on Therapeutics development in SMA
FDA on Therapeutics development in SMA
CDC on Therapeutics development in SMA
Therapeutics development in SMA in the news
Blogs on Therapeutics development in SMA
Directions to Hospitals Treating Therapeutics development in SMA
Risk calculators and risk factors for Therapeutics development in SMA

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]